Xellera Therapeutics is a pioneering CDMO focused on advancing Cell and Gene Therapies (CGT) and Advanced Therapy Products (ATP). With expertise in GMP-compliant manufacturing, Xellera helps accelerate the transition from research to commercialization — ensuring every therapy is produced with the highest standards of quality, safety, and reliability for patients worldwide.